Reported about 1 year ago
The impact of the US-China trade war has led to a reshuffle in industries, prompting Taiwan's biotech industry to ride the wave of the US 'Biological Security Act' by setting up factories in the US. Major companies like Bora Biotechnology, Taiyao, and Nanomeditech are making moves, with initial investments starting at around 8 billion NTD, setting a new record for Taiwanese biotech investments in the US. The trend is expected to continue as companies like Bora Biotechnology are leading the charge with significant acquisitions and expansions in the American market.
Source: YAHOO